Cardiology Headline News

Health care has experienced a wave of technological advancements — such as AI, machine learning and wearables — in recent years, but if unchecked, they may exacerbate existing disparities in treatment and care.

In this episode, host Hansa Bhargava, MD, discusses physician burnout, mindfulness and the effects of stress on heart health with Jonathan Fisher, MD, FACC.

Adults with primary aldosteronism had improvements in disease severity after undergoing an adrenalectomy, according to findings published in Endocrine Practice.

ORLANDO, Fla. — Cell-based therapies and enzyme inhibitors currently in development are likely to become the next-generation treatments for ambulatory and non-ambulatory forms of muscular dystrophy, according to a speaker.

Physicians can use social media to combat medical misinformation that spreads through it, according to a speaker at the Osteopathic Medical Education Conference.

AstraZeneca announced its rare disease unit, Alexion, has been granted fast track designation by the FDA for ALXN2220 for the treatment of transthyretin amyloidosis with cardiomyopathy.

Optimal heart health during the first trimester of pregnancy was associated with lower risk for hypertensive disorders of pregnancy, a speaker reported.

The FDA approved the SPIRARE II trial set to evaluate the use of Jupiter Endovascular’s Vertex Pulmonary Embolectomy System with Endoportal Control in patients with acute pulmonary embolism, according to a press release.

SGLT2 inhibition may prevent cancer therapy-related cardiac dysfunction and improve other outcomes in patients with diabetes undergoing cancer therapy, researchers reported.

Hospital admissions for heart attack increased after exposure to lower air temperature and cold spells, researchers reported at the European Society of Cardiology Congress.